CCNA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.344600E-01
Normal-vs-Stage2
4.195000E-01
Normal-vs-Stage3
8.762600E-01
Normal-vs-Stage4
6.067400E-01
Stage1-vs-Stage2
4.344200E-01
Stage1-vs-Stage3
9.391200E-01
Stage1-vs-Stage4
6.817200E-01
Stage2-vs-Stage3
4.619000E-01
Stage2-vs-Stage4
9.367400E-01
Stage3-vs-Stage4
6.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.662800E-01
Normal-vs-AfricanAmerican
7.838000E-01
Normal-vs-Asian
4.677000E-01
Caucasian-vs-AfricanAmerican
4.968000E-01
Caucasian-vs-Asian
9.296600E-01
AfricanAmerican-vs-Asian
5.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.264600E-01
Normal-vs-Female
4.206600E-01
Male-vs-Female
2.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.341400E-01
Normal-vs-Age(41-60Yrs)
3.681600E-01
Normal-vs-Age(61-80Yrs)
5.524000E-01
Normal-vs-Age(81-100Yrs)
3.679600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.582200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.754200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.605800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.222000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.769400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.020000E-01
Normal-vs-Daily Drinker
5.232000E-01
Normal-vs-Weekly Drinker
5.886200E-01
Normal-vs-Occasional Drinker
3.762600E-01
Normal-vs-Social Drinker
4.568600E-01
Non Drinker-vs-Daily Drinker
6.000200E-01
Non Drinker-vs-Weekly Drinker
7.298600E-01
Non Drinker-vs-Occasional Drinker
9.479400E-01
Non Drinker-vs-Social Drinker
9.602800E-01
Daily Drinker-vs-Weekly Drinker
9.310200E-01
Daily Drinker-vs-Occasional Drinker
5.179000E-01
Daily Drinker-vs-Social Drinker
5.770600E-01
Weekly Drinker-vs-Occasional Drinker
6.627800E-01
Weekly Drinker-vs-Social Drinker
7.083600E-01
Occasional Drinker-vs-Social Drinker
9.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.893000E-01
Normal-vs-Grade 2
8.322800E-01
Normal-vs-Grade 3
9.299600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.216000E-03
Grade 1-vs-Grade 3
4.218000E-04
Grade 1-vs-Grade 4
6.893000E-01
Grade 2-vs-Grade 3
1.082400E-01
Grade 2-vs-Grade 4
8.322800E-01
Grade 3-vs-Grade 4
9.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.251600E-01
Normal-vs-NonDiabetic
4.359600E-01
Diabetic-vs-NonDiabetic
3.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.118200E-01
Normal-vs-NoPancreatitis
5.060200E-01
Pancreatitis-vs-NoPancreatitis
3.855400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.218800E-01
Normal-vs-N1
4.625400E-01
N0-vs-N1
9.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.759800E-02
Normal-vs-TP53-NonMutant
6.088200E-01
TP53-Mutant-vs-TP53-NonMutant
1.62159999994582E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
